09606.HK
Duality Biotherapeutics, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 104.20
−4.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.98x
- Price / sales
- 6.86x
- Price / cash flow
- -14.61x
Enterprise value
- Enterprise value
- HKD 3.7B
- EV / sales
- 3.70x
- EV / EBITDA
- -2.04x
- EV / EBIT
- -2.00x
- Market cap
- HKD 6.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026